| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.0084 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |